Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
1.
Eur J Trauma Emerg Surg ; 49(3): 1595-1602, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-36692504

RESUMO

PURPOSE: To investigate the possible protective role of syringic acid on torsion/detorsion-induced testicular injury using biochemical and histopathological approaches for the first time. METHODS: A total of 24 rats were divided into 4 groups: sham control, torsion/detorsion, torsion/detorsion + syringic acid (50 mg/kg and 100 mg/kg). Tissue malondialdehyde, total oxidant status and total antioxidant status levels were determined using colorimetric methods. Tissue 8-hydroxy-2'-deoxyguanosine, superoxide dismutase, catalase, high mobility group box 1, nuclear factor kappa B protein 65, tumor necrosis factor-alpha, interleukin-6, myeloperoxidase, 78-kDa glucose-regulated protein, activating transcription factor-6, C/EBP homologous protein and caspase-3 levels were determined using commercial enzyme-linked immunosorbent assay kits. Johnsen's testicle scoring system was used for histological evaluation. RESULTS: Compared with the control group, the levels of oxidative stress, inflammation, endoplasmic reticulum stress and apoptosis were significantly increased in the torsion/detorsion group (p < 0.05). Syringic acid administrations statistically significantly restored these damage in a dose dependent manner (p < 0.05). Moreover, it was found that the results of histological examinations supported the biochemical results to a statistically significant extent. CONCLUSION: The overall results suggest that syringic acid emerges as a potential compound for the treatment of testicular torsion and may be subject to clinical trials.


Assuntos
Proteína HMGB1 , Testículo , Masculino , Ratos , Animais , Testículo/metabolismo , Testículo/patologia , NF-kappa B/metabolismo , Proteína HMGB1/metabolismo , Estresse do Retículo Endoplasmático , Reperfusão , Isquemia
2.
Eat Weight Disord ; 22(2): 249-257, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28434177

RESUMO

PURPOSE: We aimed to determine the prevalence estimates of binge eating disorder, bulimia nervosa, anorexia nervosa, and food addiction in men with heroin use disorder and a matched sample of control participants. METHODS: A group of 100 men with heroin use disorder, consecutively admitted to a detoxification and therapy unit, were screened for DSM-5 eating disorders, along with a group of 100 male controls of similar age, education, and body mass index. The Yale Food Addiction Scale (YFAS), the Barratt Impulsivity Scale-version 11, and the Eating Attitudes Test were used for data collection. Patients were also evaluated for various aspects of heroin use disorder (e.g., craving) using the Addiction Profile Index. RESULTS: Binge eating disorder that met DSM-5 criteria was more prevalent in patients with heroin use disorder (21%) than in control subjects (8%) (odds ratio 3.1, 95% confidence interval 1.3-7.3; p < 0.01). Food addiction based on the YFAS was also more common among men with heroin use disorder (28%) than among control participants (12%) (odds ratio 2.9, 95% confidence interval 1.4-6.1; p < 0.01). A current food addiction was associated with more severe craving and having a history of suicide attempts in the patients. CONCLUSIONS: Co-occurring binge eating disorder and food addiction are highly frequent in men with heroin use disorder. Screening for binge eating disorder and food addiction in patients with substance use disorder is important, as interventions may improve treatment outcome in this patient group.


Assuntos
Transtornos da Alimentação e da Ingestão de Alimentos/epidemiologia , Dependência de Alimentos/epidemiologia , Dependência de Heroína/epidemiologia , Adulto , Comorbidade , Manual Diagnóstico e Estatístico de Transtornos Mentais , Transtornos da Alimentação e da Ingestão de Alimentos/diagnóstico , Transtornos da Alimentação e da Ingestão de Alimentos/psicologia , Dependência de Alimentos/diagnóstico , Dependência de Alimentos/psicologia , Dependência de Heroína/diagnóstico , Dependência de Heroína/psicologia , Humanos , Masculino , Prevalência , Adulto Jovem
3.
Int J Ophthalmol ; 8(1): 72-6, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25709911

RESUMO

AIM: To determine the effect of refractive error on temperament and character properties using Cloninger's psychobiological model of personality. METHODS: Using the Temperament and Character Inventory (TCI), the temperament and character profiles of 41 participants with refractive errors (17 with myopia, 12 with hyperopia, and 12 with myopic astigmatism) were compared to those of 30 healthy control participants. Here, temperament comprised the traits of novelty seeking, harm-avoidance, and reward dependence, while character comprised traits of self-directedness, cooperativeness, and self-transcendence. RESULTS: Participants with refractive error showed significantly lower scores on purposefulness, cooperativeness, empathy, helpfulness, and compassion (P<0.05, P<0.01, P<0.05, P<0.05, and P<0.01, respectively). CONCLUSION: Refractive error might have a negative influence on some character traits, and different types of refractive error might have different temperament and character properties. These personality traits may be implicated in the onset and/or perpetuation of refractive errors and may be a productive focus for psychotherapy.

4.
Arch Womens Ment Health ; 18(5): 739-40, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25599999

RESUMO

Long-acting antipsychotic use in schizophrenia has become an advantage for treatment compliance and convenient administration of the drugs. There is no data on paliperidone palmitate (PP) use in pregnancy, which is the longest-acting (i.e., 1 month) atypical antipsychotic. In this case report, we aim to present a patient diagnosed with schizophrenia who had been using PP before and during her pregnancy until week 28 of gestation and gave birth to a male baby that weighed 3000 g at 39 weeks. As far as we know, this is the first case report on PP use during pregnancy.


Assuntos
Antipsicóticos/administração & dosagem , Palmitato de Paliperidona/administração & dosagem , Esquizofrenia/tratamento farmacológico , Adulto , Antipsicóticos/uso terapêutico , Esquema de Medicação , Feminino , Humanos , Injeções Intramusculares , Masculino , Palmitato de Paliperidona/uso terapêutico , Gravidez , Complicações na Gravidez/psicologia , Escalas de Graduação Psiquiátrica , Esquizofrenia/diagnóstico , Psicologia do Esquizofrênico , Resultado do Tratamento
5.
J Sex Med ; 10(11): 2849-54, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23898895

RESUMO

INTRODUCTION: Sexual adjustment and long-term results following vaginal reconstruction with free vascular jejunal flap are not well known. AIMS: The study aims to investigate sexual adjustment and long-term results among patients who underwent vaginal reconstruction with free vascular jejunal flap. METHODS: A total of 34 women, aged 16-31 years (mean 23.5), who underwent vaginal reconstruction with a vascular jejunal flap between 2005 and 2011 were evaluated. Indications for reconstruction included the following: Mayer Rokitansky Kuster Hauser syndrome (29 patients), isolated vaginal agenesis (2 patients), androgen insensitivity syndrome (2 patients), and (1) history of gynecologic-oncologic surgery. MAIN OUTCOME MEASURES: The study evaluates the perioperative results, complications, satisfaction with sexual function, length and width of the neovagina. RESULTS: All of the surgeries were completed without any intraoperative complications. Three patients required reoperation because of postoperative venous compromise in the grafts. The flap success rate was 100%, and no infection was observed for any case. The mean follow-up was 50 months (between 20 and 87 months). The mean vaginal depth and diameter were satisfactory for all cases. Postoperatively, six patients complained of jejunal hypersecretion, one patient complained of mucosal prolapse, and one patient complained of vaginal constriction. The neovaginal prolapse was repaired via minor surgery. Twenty-seven were married and sexually active. Twenty patients completed the questionnaire on sexual function. Sexual function was assessed using the Female Sexual Function Index (FSFI). Eleven patients were satisfied with their sexual lives after surgery (FSFI scores≥25). CONCLUSION: Based on our results, satisfactory sexual function was achieved using the free jejunal vascular flap.


Assuntos
Transtornos 46, XX do Desenvolvimento Sexual/cirurgia , Anormalidades Congênitas/cirurgia , Jejuno/cirurgia , Ductos Paramesonéfricos/anormalidades , Retalhos Cirúrgicos , Vagina/cirurgia , Adolescente , Adulto , Feminino , Procedimentos Cirúrgicos em Ginecologia/métodos , Humanos , Jejuno/irrigação sanguínea , Masculino , Ductos Paramesonéfricos/cirurgia , Procedimentos de Cirurgia Plástica/métodos , Comportamento Sexual/fisiologia , Ajustamento Social , Inquéritos e Questionários , Vagina/fisiopatologia , Adulto Jovem
6.
Fertil Steril ; 100(5): 1358-63, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23830110

RESUMO

OBJECTIVE: To present the first clinical pregnancy after uterus transplantation. DESIGN: Case study. SETTING: Tertiary center. PATIENT(S): A 23-year-old Mayer-Rokitansky-Kuster-Hauser syndrome patient with previous vaginal reconstruction and uterus transplantation. INTERVENTION(S): Eighteen months after the transplant, the endometrium was prepared for transfer of the thawed embryos. MAIN OUTCOME MEASURE(S): Implantation of embryo in an allografted human uterus. RESULT(S): The first ET cycle with one day 3 thawed embryo resulted in a biochemical pregnancy. The second ET cycle resulted in a clinical pregnancy confirmed with transvaginal ultrasound visualization of an intrauterine gestational sac with decidualization. CONCLUSION(S): We have presented the first clinical pregnancy in a patient with absolute uterine infertility after uterus allotransplantation. Although the real success is the delivery of a healthy near-term baby, this clinical pregnancy is a great step forward and a proof of concept that the implantation phase works.


Assuntos
Transtornos 46, XX do Desenvolvimento Sexual/cirurgia , Anormalidades Congênitas/cirurgia , Fertilidade , Infertilidade Feminina/cirurgia , Ductos Paramesonéfricos/anormalidades , Útero/cirurgia , Transtornos 46, XX do Desenvolvimento Sexual/fisiopatologia , Aborto Espontâneo/etiologia , Anormalidades Congênitas/fisiopatologia , Implantação do Embrião , Transferência Embrionária , Feminino , Fármacos para a Fertilidade Feminina/uso terapêutico , Fertilização in vitro , Idade Gestacional , Humanos , Infertilidade Feminina/fisiopatologia , Ductos Paramesonéfricos/fisiopatologia , Ductos Paramesonéfricos/cirurgia , Gravidez , Resultado do Tratamento , Útero/anormalidades , Útero/fisiopatologia , Adulto Jovem
7.
Fertil Steril ; 99(2): 470-6, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23084266

RESUMO

OBJECTIVE: To describe the first-year results of the first human uterus transplantation case from a multiorgan donor. DESIGN: Case study. SETTING: University hospital. PATIENT(S): A 21-year-old woman with complete müllerian agenesis who had been previously operated on for vaginal reconstruction. INTERVENTION(S): Uterus transplantation procedure consisting of orthotopic replacement and fixation of the retrieved uterus, revascularization, end to site anastomoses of bilateral hypogastric arteries and veins to bilateral external iliac arteries and veins was performed. MAIN OUTCOME MEASURE(S): Resumption of menstrual cycles. RESULT(S): The patient had menarche 20 days after transplant surgery. She has had 12 menstrual cycles since the operation. CONCLUSION(S): We have described the longest-lived transplanted human uterus to date with acquirement of menstrual cycles.


Assuntos
Útero/anormalidades , Útero/transplante , Vagina/anormalidades , Vagina/cirurgia , Anastomose Cirúrgica/métodos , Feminino , Humanos , Ciclo Menstrual/fisiologia , Projetos Piloto , Obtenção de Tecidos e Órgãos , Resultado do Tratamento , Útero/fisiologia , Útero/cirurgia , Adulto Jovem
8.
Int J Soc Psychiatry ; 57(3): 237-47, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-19906770

RESUMO

AIMS: The aims of this study were to determine the characteristics of self-mutilation (SM) and examine the relationship between SM and psychopathy in male subjects with antisocial personality disorder (APD). METHODS: APD diagnosis was established by the Structured Clinical Interview for DSM-III-R Axis II Disorders. Subjects (N = 116) were assessed using the Psychopathy Checklist-Revised and a semi-structured self-mutilation questionnaire form. RESULTS: In males with APD, the percentages of psychopathy and SM were 48.3% (N =56) and 96.6% (N = 112), respectively. There were positive correlations between severity of psychopathy and severity, number, and frequency of SM. CONCLUSION: Considerably high rates of SM and psychopathy were found in Turkish males with APD. The features of SM were associated with comorbidity of psychopathy. These results showed the importance of exploring the self-injurious behavior and psychopathy when diagnosed with APD.


Assuntos
Transtorno da Personalidade Antissocial/diagnóstico , Transtorno da Personalidade Antissocial/psicologia , Países em Desenvolvimento , Automutilação/diagnóstico , Automutilação/psicologia , Transtorno da Personalidade Antissocial/epidemiologia , Lista de Checagem , Criança , Maus-Tratos Infantis/diagnóstico , Maus-Tratos Infantis/psicologia , Maus-Tratos Infantis/estatística & dados numéricos , Crime/psicologia , Crime/estatística & dados numéricos , Humanos , Entrevista Psicológica , Acontecimentos que Mudam a Vida , Masculino , Determinação da Personalidade/estatística & dados numéricos , Psicometria , Automutilação/epidemiologia , Turquia , Adulto Jovem
9.
Aesthetic Plast Surg ; 34(3): 359-64, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20108091

RESUMO

BACKGROUND: Reduction mammaplasty improves self-esteem and low body perception. Previous reports comprise either retrospective data or sectional analysis in which women were evaluated postoperatively. Furthermore, temperament and character properties of women applying for breast reduction have not been investigated. This study aimed to compare the temperament and character traits of women admitted for breast reduction surgery with those of healthy volunteers and to investigate the interaction of body perception with temperament and character. METHODS: The study enrolled 24 patients admitted for reduction mammaplasty and 24 healthy women. The study participants received the Temperament and Character Inventory (TCI) and the Rosenberg Self-Esteem Scale (RSE) questionnaires. The RSE questionnaire was completed again by the patients 6 months after the operation. RESULTS: Of the temperament scales, the persistence scale was significantly lower for the patients. Only the reward dependence subscale of the temperament scale was significantly higher for the patients. Self-esteem (RSE) was significantly lower for the patients than for the control subjects preoperatively, whereas, it rose significantly after the operation. The RSE showed a negative correlation with self-directedness and its subscales of being responsible and resourceful. A significant negative correlation also was found between RSE and empathy. CONCLUSIONS: Women with large breasts try to develop adaptable character properties against chronic troubles. However, the temperament scale of persistence decreases in this process. Similar temperament and character traits of women with and those without large breasts suggest that patients desire breast reduction for functional rather than cosmetic purposes.


Assuntos
Imagem Corporal , Caráter , Mamoplastia/psicologia , Autoimagem , Temperamento , Adulto , Feminino , Humanos , Inquéritos e Questionários
10.
Ann Nucl Med ; 24(2): 67-76, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20058104

RESUMO

OBJECTIVES: Nuclear medicine procedures use radiopharmaceuticals, which produce radiation and potential adverse reactions, albeit at a low rate. It is the patient's ethical, legal, and medical right to be informed of the potential side effects of procedures applied to them. Our purpose was to determine the effect of providing information about intravenous radiopharmaceutical administration on the anxiety level of patients who request more information. MATERIALS AND METHODS: This study was completed in two separate Nuclear Medicine Departments. The study included 620 (247 M, 373 F) patients who had been referred for myocardial perfusion, bone, dynamic renal, and thyroid scintigraphic examinations. The patients were divided into two groups according to whether they requested more information or not. Group 1 consisted of 388 patients who wanted to receive more information about the procedure, while Group 2 consisted of 232 patients who did not request additional information. The State-Trait Anxiety Inventory (STAI-S and STAI-T) was used to determine a patient's anxiety level. After simple information was given, state and trait anxiety levels were measured in both groups. We gave detailed information to the patients in Group 1 and then measured state anxiety again. Detailed information included an explanation of the radiopharmaceutical risk and probable side effects due to the scan procedure. RESULTS: There was no statistical difference between Groups 1 and 2 in STAI-T or STAI-S scores after simple information was given (p = 0.741 and p = 0.945, respectively). The mean value of STAI-S score was increased after the provision of detailed information and there was a statistically significant difference between after simple information SATI-S and after detailed information STAI-S (p < 0.001). The STAI-S score was increased in 246 patients and decreased in 110 patients after detailed information, while there was no change in 32 patients. After detailed information, the greatest increase in STAI-S score was seen in the myocardial perfusion scan patients, when evaluating according to scan procedure (p < 0.001). However, in the dynamic renal patient group, there was no statistical difference (p = 0.271). CONCLUSIONS: Informed consent including detailed information about radiation exposure, the risk factors, and potential adverse reactions of intravenous radiopharmaceutical administration increased the patients' anxiety level in those who request more information.


Assuntos
Acesso à Informação , Ansiedade , Revelação , Compostos Radiofarmacêuticos/administração & dosagem , Adolescente , Adulto , Idoso , Ansiedade/diagnóstico , Demografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Compostos Radiofarmacêuticos/efeitos adversos , Risco , Adulto Jovem
11.
Int J Psychiatry Med ; 39(3): 297-312, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19967901

RESUMO

OBJECTIVE: Recently, the increasing rate of obesity has been elucidated as a major public health problem. The aim of this study was to examine the psychological distress, subjective sleep quality, and health-related quality of life (HRQOL) in a group of patients diagnosed with obesity. METHODS: A total of 124 obese patients (32 of them Class I obesity (BMI: 30-34.9 kg/m2), 92 Class II obesity (BMI: > or = 35kg/m2)) and 106 healthy control subjects were involved in the study. Subjects were evaluated with self-administered questionnaires including the Symptoms Checklist-90-Revised (SCL-90-R), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and Short Form 36 (SF-36). Several clinical and socio-demographic data were also recorded. RESULTS: Class II obesity group had a significantly worse psychological status, quality of life, and sleep quality than control group, Although Class I obesity group did not differ from Class II and control groups according to sleep quality and psychological status, they had worse HRQOL than the control group. BMI scores positively correlated with the majority of subscales of psychological distress (SCL-90-R) and sleep quality (PSQI, ESS) and negatively correlated with all dimensions of HRQOL (SF-36). CONCLUSIONS: Obesity is associated with psychological distress, poor sleep quality, and reduced quality of life. Thus, obesity should be evaluated in a biopsychosocial manner, including management of patients' psychopathology.


Assuntos
Nível de Saúde , Transtornos Mentais/epidemiologia , Obesidade/epidemiologia , Qualidade de Vida , Transtornos do Sono-Vigília/epidemiologia , Adulto , Análise de Variância , Estudos de Casos e Controles , Comorbidade , Humanos , Masculino , Análise por Pareamento , Obesidade/psicologia , Estresse Psicológico/epidemiologia , Turquia/epidemiologia
12.
J Psychosom Obstet Gynaecol ; 29(2): 91-5, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18655256

RESUMO

OBJECTIVE: To investigate the association between either depression or anxiety early in pregnancy, and nausea and vomiting, in a clinical sample. METHODS: Anxiety and depression scores of 230 women were investigated by using the Hospital Anxiety and Depression Scale. Nausea and vomiting of pregnancy (NVP) were scored by using the Rhode's system. These scores and demographic data were compared and P < 0.05 was considered significant. RESULTS: A significant correlation between Rhode's score and both anxiety (r=0.388, P < 0.001) and depression score, (r=0.351, P < 0.001) was found. Gestational age showed and inverse correlation with anxiety scores (P=0.019). There was no significant correlation between demographic data and anxiety/depression scores, or Rhode's scores. CONCLUSION: There is an association between anxiety and depression early in pregnancyand severity of NVP.


Assuntos
Ansiedade/psicologia , Depressão/psicologia , Êmese Gravídica/psicologia , Adolescente , Adulto , Estudos Transversais , Feminino , Humanos , Êmese Gravídica/epidemiologia , Gravidez , Primeiro Trimestre da Gravidez , Estudos Prospectivos , Reprodutibilidade dos Testes , Índice de Gravidade de Doença , Turquia/epidemiologia
13.
Compr Psychiatry ; 49(2): 154-8, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18243887

RESUMO

OBJECTIVE: The principal aim of this study was to assess the current prevalence rate of panic disorder (PD) in pregnant women during the third trimester of pregnancy. The second aim of the present study was to investigate the clinical characteristics of PD in pregnant and nonpregnant women. METHOD: The study data were gathered from 512 consecutive women in the third trimester of pregnancy who were admitted to the obstetric outpatient clinics of 2 university research centers. The diagnosis of PD was determined by means of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Axis I disorders in the third trimester of pregnancy. Within the same period, the Panic and Agoraphobia Scale was used to determine the severity of PD. In addition, we compared the clinical characteristics of PD in gravid subjects (n = 13) with their control group. A control group was composed of 19 consecutive nonpregnant female outpatients diagnosed with PD who presented to the psychiatric outpatient clinics of the same hospitals. RESULTS: The prevalence rate of PD was found to be 2.5% (n = 13) among the subjects in the third trimester of pregnancy. Of these 13 pregnant, 7 subjects reported that PD developed during the 6th to 28th weeks of their gestation, and the number of subjects who experienced PD symptoms before pregnancy was 6. In addition, there was no statistically difference between gravid and nongravid PD cases with regard to the severity of panic symptoms. CONCLUSION: Our study suggests that PD may be common among pregnant females during the third trimester of pregnancy and seems to be associated with similar clinical features during gestation and nongestation.


Assuntos
Transtorno de Pânico/epidemiologia , Adolescente , Adulto , Feminino , Humanos , Transtorno de Pânico/diagnóstico , Transtorno de Pânico/psicologia , Gravidez , Complicações na Gravidez , Terceiro Trimestre da Gravidez , Prevalência , Índice de Gravidade de Doença
14.
Int J Psychiatry Clin Pract ; 12(2): 134-7, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-24916624

RESUMO

Aim. To examine the effects of obsessive-compulsive disorder (OCD) on quality of life in pregnant women. Material and method. Twenty-five pregnant women diagnosed as OCD in two university outpatient clinics were included for the study. Twenty-five pregnant women with no mental disorders and the same sociodemographic properties were taken as the control group. The diagnosis of OCD was confirmed with the DSM-IV Axis-I Disorders Structured Clinic Interview Diagnosis/Clinic Version (SCID-I/CV). In order to measure the severity of OCD Yale-Brown Obsession and Compulsion Scale was performed. Quality of life was evaluated by WHO (World Health Organisation) Life Quality Scale - Short Form (WHOQOL-Brief). Results. The whole subgroup of points of WHOQOL-Brief was significantly lower in OCD patients compared to control group (in all subgroups P<0.01). There was a negative correlation between the Y-BOCS obsession and compulsion subpoints and total points with the physical health (P <0.05), psychological health (P <0.001) and social relationship (P <0.01) of WHOQOL-Brief. No significant association was found with enviromental areas. Besides, there was a negative correlation between the duration of OCD and WHOQOL-Brief psychological health subarea (P <0.05). Conclusion. OCD negatively effects the quality of life in pregnant women and is correlated with the severity of the disorder.

15.
Compr Psychiatry ; 49(1): 30-4, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18063038

RESUMO

PURPOSE: Most of the studies about course of panic disorder (PD) after childbirth have a retrospective nature. The aim of the current study was to examine prospectively the clinical course of 13 pregnant women with a diagnosis of PD across pregnancy and the early postpartum period. METHOD: The diagnosis of PD was determined by means of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Axis I Disorders in the third trimester of pregnancy. Within the same period, the Panic and Agoraphobia Scale was used to determine the severity of PD. The last assessment with both instruments was performed at 6 weeks postnatally. RESULTS: Of these 13 women, 6 (group 1) reported that PD developed during the 6th to the 28th week of their gestation, and the number of women who experienced PD symptoms before pregnancy (group 2) was 7. It was found that the severity of panic symptoms considerably decreased in the total sample, group 1, and group 2 from the basal levels to 6 weeks postnatally. CONCLUSION: Our study results suggest that pregnant women with PD may experience a marked improvement in PD symptoms in the early postpartum period.


Assuntos
Transtorno de Pânico/psicologia , Período Pós-Parto/psicologia , Adulto , Feminino , Humanos , Gravidez , Trimestres da Gravidez , Estudos Prospectivos , Escalas de Graduação Psiquiátrica , Índice de Gravidade de Doença
16.
Tuberk Toraks ; 55(3): 271-7, 2007.
Artigo em Turco | MEDLINE | ID: mdl-17978925

RESUMO

Obstructive sleep apnea syndrome (OSAS) causes numerous pathophysiological changes and influences neuropsychological system. Nasal continuous positive airway pressure (CPAP) is the gold standard treatment of OSAS. We aimed to evaluate the compliance of patients with severe OSAS to CPAP treatment and to compare the anxiety and depression scores before and at the 6th month of the treatment. Seventeen patients receiving CPAP treatment for OSAS that continued regular follow-up were accepted to the study. A questionnaire containing questions about demographic features, OSAS symptoms and Epworth sleepiness scale, Beck anxiety scale and depression scale was filled by the patients before and after CPAP treatment. Additionally, information concerning adverse effects of and compliance to CPAP treatment was obtained after CPAP treatment. Mean age of the patients was 48.4 +/- 8.4 (32-63); 14 (82.4%) of them were male and 3 (17.6%) of them were female. Snoring, witnessed apnea and excessive daytime sleepiness symptoms, and Epworth sleepiness scale scores were significantly decreased after CPAP treatment compared with those before treatment. Mean duration of CPAP device use at night was 5.6 +/- 2.1 (2-8) hours. Nine (52.9%) of the patients were using the device regularly every night and 8 (47.1%) of the patients were using it irregularly. The most frequent adverse effect of CPAP treatment was sore mouth, followed by mask discomfort and erythema on the nose. Anxiety and depression scores of the patients were significantly decreased after CPAP treatment compared with those before the treatment. As a conclusion, OSAS patients with high anxiety and depression scores benefit from CPAP treatment.


Assuntos
Pressão Positiva Contínua nas Vias Aéreas , Transtorno Depressivo/psicologia , Apneia Obstrutiva do Sono/psicologia , Apneia Obstrutiva do Sono/terapia , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Cooperação do Paciente , Escalas de Graduação Psiquiátrica , Inquéritos e Questionários , Resultado do Tratamento , Turquia
17.
Compr Psychiatry ; 48(6): 558-61, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17954142

RESUMO

OBJECTIVE: The aim of the current study was to prospectively examine a course of obsessive-compulsive disorder (OCD) during the early postpartum period. METHOD: The study data were collected from 16 pregnant women with a diagnosis of OCD according to the Structured Clinical Interview for DSM-IV (SCID-I). Obsessive-compulsive disorder symptoms were assessed by the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) before and after childbirth. Psychopharmacologic or psychotherapeutic treatments were not administered over the study period. RESULTS: Scores of the mean Y-BOCS-total and Y-BOCS-obsession were significantly reduced from the basal levels to 6 weeks postnatally. No significant difference was found in terms of Y-BOCS-compulsion between 2 interviews. During the study period, whereas the Y-BOCS-total scores were decreased by at least 25% in 8 (50.0%) of 16 patients, only 1 (6.2%) of 16 patients experienced at least a 25% increase in the same scores. CONCLUSION: The results from a small patient group suggest that some patients may experience a marked improvement in preexisting OCD symptoms after childbirth.


Assuntos
Transtorno Obsessivo-Compulsivo/psicologia , Período Pós-Parto , Adulto , Feminino , Humanos , Gravidez , Estudos Prospectivos , Escalas de Graduação Psiquiátrica , Índice de Gravidade de Doença
18.
Neurosci Lett ; 426(1): 49-53, 2007 Oct 09.
Artigo em Inglês | MEDLINE | ID: mdl-17884293

RESUMO

The effects of electroconvulsive therapy (ECT), which is a widely used treatment for psychiatric disorders, have not yet been established. Therefore, we aimed to explore whether the patients' serum ghrelin and leptin levels are associated with the action of ECT treatment. In the case of the mood disorders, which occurred in 16 patients with major depressive episode (MDE) and 12 patients with bipolar disorder-manic episode (BD-me) and 25 healthy controls, we have determined the serum levels of ghrelin, leptin and cholesterol before ECT and 2 days after ECT. The BMI was also calculated in all subjects. Although ECT treatment did not change mean the BMI and serum leptin level, the mean serum ghrelin level decreased and the total cholesterol level increased after ECT compared with before ECT. While the leptin levels in the patient group were significantly lower than the controls before and after ECT, the mean serum ghrelin and total cholesterol levels differed statistically only before ECT, but not after ECT than those in controls. The ghrelin levels have decreased significantly after ECT in both sub-groups MDE and BB-me. However, the mean serum total cholesterol level increased statistically after ECT only in the MDE sub-group, and the leptin levels did not differ in both sub-groups after ECT compared with before ECT. In conclusion, ECT treatment seems to be associated with decreased ghrelin levels and increased cholesterol levels but not leptin levels. However, more comprehensive and detailed studies are needed to decipher the exact role of ECT on ghrelin, leptin and total cholesterol in mood disorders.


Assuntos
Colesterol/sangue , Eletroconvulsoterapia , Grelina/sangue , Leptina/sangue , Transtornos do Humor/sangue , Transtornos do Humor/terapia , Adulto , Biomarcadores/análise , Biomarcadores/sangue , Transtorno Bipolar/sangue , Transtorno Bipolar/fisiopatologia , Transtorno Bipolar/terapia , Encéfalo/metabolismo , Encéfalo/fisiopatologia , Química Encefálica/fisiologia , Transtorno Depressivo/sangue , Transtorno Depressivo/fisiopatologia , Transtorno Depressivo/terapia , Regulação para Baixo/fisiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos do Humor/fisiopatologia , Resultado do Tratamento , Regulação para Cima/fisiologia
19.
Compr Psychiatry ; 48(5): 441-5, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17707252

RESUMO

OBJECTIVE: The principal aims of this study were to examine the current prevalence rate, clinical characteristics, and related factors of obsessive-compulsive disorder (OCD) in pregnant women during the third trimester of pregnancy. METHOD: The study data were gathered from 434 consecutive women in the third trimester of pregnancy who presented to the obstetric outpatient clinics of 2 university research centers and from 58 consecutive nonpregnant women with diagnosed with OCD who presented to the psychiatric outpatient clinics of the same centers. Obsessive-compulsive disorder was diagnosed by means of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. The Yale-Brown Obsessive-Compulsive Scale was used to determine the severity and types of obsessions and compulsions. RESULTS: The prevalence rate of OCD was found to be 3.5% among the women in the third trimester of pregnancy. Two (0.5%) women reported that OCD developed during the second trimester (16th and 24th gestational weeks) of pregnancy. The most common obsessions were contamination (80.0%) and symmetry/exactness (60.0%), whereas the most common compulsions were cleaning/washing (86.7%) and checking (60.0%). Women with pregnancy-onset OCD and some women with previous diagnoses of OCD had obsessions and compulsions with themes focused on the fetus or newborn. Pregnant women with OCD had higher frequencies of family history of OCD compared with women without this disorder. Age, educational level, employment status, number of gestations and live births, history of abortion, frequency of primigravida, and the existence of gestational complications were unrelated to OCD in the pregnant women. Pregnant and nonpregnant women with OCD had similar characteristics of obsessive-compulsive symptoms. CONCLUSION: Our study suggests that OCD is present relatively frequently among pregnant women during the third trimester of pregnancy, and it has similar clinical features during gestation and nongestation.


Assuntos
Transtorno Obsessivo-Compulsivo/epidemiologia , Transtorno Obsessivo-Compulsivo/psicologia , Complicações na Gravidez/epidemiologia , Complicações na Gravidez/psicologia , Adulto , Manual Diagnóstico e Estatístico de Transtornos Mentais , Feminino , Humanos , Transtorno Obsessivo-Compulsivo/diagnóstico , Gravidez , Complicações na Gravidez/diagnóstico , Terceiro Trimestre da Gravidez , Prevalência , Índice de Gravidade de Doença
20.
Prog Neuropsychopharmacol Biol Psychiatry ; 31(6): 1270-4, 2007 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-17597276

RESUMO

To examine the importance of ghrelin and leptin in the pathogenesis of obsessive-compulsive disorder (OCD), we measured serum ghrelin and leptin levels, lipid profile and body mass index (BMI) in 43 patients with OCD and 20 healthy controls. The patients were divided into two subgroups according to whether DSM-IV OCD was accompanied with major depressive disorder (MDD) (OCD+MDD) or not (OCD-MDD). There was no statistically significant difference in ghrelin and leptin levels between groups. The OCD+MDD group had a trend of higher ghrelin levels and lower leptin levels than the OCD-MDD and control groups. There was a negative correlation between change in serum ghrelin and leptin levels only in the OCD+MDD group. Neither ghrelin nor leptin showed any correlation with severity of MDD and OCD. In conclusion, our results suggest that OCD is not associated with leptin or ghrelin levels. More comprehensive and detailed studies are needed to decipher the exact role of ghrelin and leptin in OCD.


Assuntos
Leptina/sangue , Transtorno Obsessivo-Compulsivo/sangue , Hormônios Peptídicos/sangue , Adolescente , Adulto , Análise de Variância , Índice de Massa Corporal , Distribuição de Qui-Quadrado , Depressão/sangue , Depressão/complicações , Feminino , Grelina , Humanos , Técnicas Imunoenzimáticas , Masculino , Pessoa de Meia-Idade , Transtorno Obsessivo-Compulsivo/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA